AbCellera Biologics Inc (NASDAQ: ABCL) is -24.91% lower on its value in year-to-date trading and has touched a low of $2.20 and a high of $5.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.33 in the last trading session, with the day’s loss setting it -0.13%.
Currently trading at $2.20, the stock is -22.51% and -27.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.61 million and changing -5.58% at the moment leaves the stock -24.78% off its SMA200. ABCL registered -54.83% loss for a year compared to 6-month gain of -9.47%.
The stock witnessed a -33.13% loss in the last 1 month and extending the period to 3 months gives it a -24.14%, and is -6.78% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.16% over the week and 7.59% over the month.
AbCellera Biologics Inc (ABCL) has around 596 employees, a market worth around $655.57M and $28.83M in sales. Profit margin for the company is -564.81%. Distance from 52-week low is 0.00% and -57.07% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.58%).
with sales reaching $7.12M over the same period.The EPS is expected to shrink by -10.53% this year, but quarterly earnings will post -8.82% year-over-year. Quarterly sales are estimated to shrink -28.43% in year-over-year returns.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
The shares outstanding are 295.76M, and float is at 223.90M with Short Float at 8.98%.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.3556% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4472 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.8078 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
#####
